New TB vaccines show promise but fall short of full protection

Two new TB vaccines, VPM1002 and Immuvac, showed safety and immune response in a large Phase-3 trial in India but failed to fully protect against all forms of tuberculosis. Experts highlight that proper nutrition is crucial, as underweight individuals showed limited vaccine effectiveness in preventing the disease.